Brian Lian - President & CEO, Director at Viking Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
VKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Brian Lian - trading volume in the past year for Viking Therapeutics, Inc.

Holdings reported by Brian Lian for Viking Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.00001 per share 2.27M $189M $83.34 Mar 27, 2024 Direct
Common Stock, par value $0.00001 per share 2.3M $166M $71.99 Sep 20, 2024 Direct
Stock Option (Right to Buy) 65K Sep 20, 2024 Direct Common Stock

Transactions reported by Brian Lian for Viking Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.